🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, randomized, phase III study. It is aim...
Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Start Date
2022-06-20
Trial ID
NCT04841811
Treatments Being Tested
Pediatric soft tissue sarcoma is made up of different subtypes, some of whi...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-10-01
Trial ID
NCT05778955
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) carries one of the worst prognoses ...
Status
Not Yet Recruiting
Location
Linkou Chang Gung Memorial Hospital
Start Date
2026-09-01
Trial ID
NCT07597252
For patients with newly diagnosed or relapsed/metastatic B-cell non-Hodgkin...
Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-01-01
Trial ID
NCT07480837
The second generation of high-throughput gene sequencing (NGS) is an import...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2017-10-21
Trial ID
NCT03465241
Treatments Being Tested
For patients with stage III colon cancers, radical resection of primary tum...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-11-01
Trial ID
NCT05161585
Treatments Being Tested
Befotertinib is a third-generation EGFR-TKI independently developed in Chin...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2026-02-10
Trial ID
NCT07410611
Treatments Being Tested
This was a prospective, single-center clinical study. The study was designe...
Status
Unknown
Location
Chinese Academy of Medical Sciences
Start Date
2018-09-17
Trial ID
NCT03947736
Treatments Being Tested
1. To explore the predictive value of ctDNA in HER2 positive breast cancer ...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2024-03-08
Trial ID
NCT06479460
Treatments Being Tested
This study will utilize ctDNA methylation detection to evaluate patients wi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-11-01
Trial ID
NCT07562659
Treatments Being Tested